Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Intelligent Medicine Acquisition Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/12/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
05/02/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
04/27/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/26/2023 8-K Quarterly results
04/17/2023 10-K Annual Report for the period ended December 31, 2022
04/05/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
04/03/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
02/28/2023 4 Saba Capital Management, L.P. (10% Owner) has filed a Form 4 on Intelligent Medicine Acquisition Corp.
Txns: Disposed/sold 2,170,581 shares @ $10.34, valued at $22.4M
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INTELLIGENT MEDICINE ACQUISITION CORP. Pursuant to Section 242 of the Delaware General Corporation Law"
02/03/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
02/03/2023 8-K Quarterly results
01/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
01/19/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
01/04/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
06/07/2022 3/A Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
05/17/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/17/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/09/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
03/30/2022 10-K Annual Report for the period ended December 31, 2021
02/14/2022 SC 13G/A Saba Capital Management, L.P. reports a 6.8% stake in Intelligent Medicine Acquisition Corp
02/11/2022 SC 13G/A Sculptor Capital LP reports a 4.3% stake in INTELLIGENT MEDICINE ACQUISITION CORP.
02/11/2022 SC 13G Intelligent Medicine Sponsor LLC reports a 18.9% stake in Intelligent Medicine Acquisition Corp.
02/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/27/2022 SC 13G/A HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 4.8% stake in Intelligent Medicine Acquisition Corp.
12/23/2021 8-K Quarterly results
12/20/2021 10-Q Quarterly Report for the period ended September 30, 2021
11/19/2021 SC 13G HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 5.2% stake in Intelligent Medicine Acquisition Corp.
11/15/2021 SC 13G Saba Capital Management, L.P. reports a 7.6% stake in Intelligent Medicine Acquisition Corp
11/12/2021 SC 13G Sculptor Capital LP reports a 5.6% stake in INTELLIGENT MEDICINE ACQUISITION CORP.
11/10/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Underwriting Agreement, between the Company and Cantor Fitzgerald & Co. representative of the several underwriters",
"Amended and Restated Certificate of Incorporation",
"Warrant Agreement, between Continental Stock Transfer & Trust Company and the Company",
"Warrant Purchase Agreement, between the Company and the Intelligent Medicine Sponsor, LLC",
"Warrant Purchase Agreement, between the Company and Cantor Fitzgerald & Co",
"Investment Management Trust Account Agreement, between Continental Stock Transfer & Trust Company and the Company",
"Registration and Stockholder Rights Agreement, among the Company, Intelligent Medicine Sponsor, LLC and the other Holders (as defined therein) signatory thereto",
"Letter Agreement, among the Company, Intelligent Medicine Sponsor LLC and each of the initial stockholders, directors and officers of the Company",
"Form of Indemnification Agreement, between the Company and each of the officers and directors of the Company",
"Intelligent Medicine Acquisition Corp. Announces Pricing of $150,000,000 Initial Public Offering"
11/08/2021 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy